BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Green DM, Ropper AH. Mild Guillain-Barré syndrome. Arch Neurol 2001;58:1098-101. [PMID: 11448299 DOI: 10.1001/archneur.58.7.1098] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Shang P, Zhu M, Wang Y, Zheng X, Wu X, Zhu J, Feng J, Zhang H. Axonal variants of Guillain–Barré syndrome: an update. J Neurol 2021;268:2402-2419. [DOI: 10.1007/s00415-020-09742-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 10.0] [Reference Citation Analysis]
2 Verboon C, Harbo T, Cornblath DR, Hughes RAC, van Doorn PA, Lunn MP, Gorson KC, Barroso F, Kuwabara S, Galassi G, Lehmann HC, Kusunoki S, Reisin RC, Binda D, Cavaletti G, Jacobs BC; IGOS consortium., GOS consortium. Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study. J Neurol Neurosurg Psychiatry 2021:jnnp-2020-325815. [PMID: 34103340 DOI: 10.1136/jnnp-2020-325815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Sharma A, Gankidi VR, Nizami I, Rohan R. QUADRIPARESIS - IT'S APPROACH AND MANAGEMENT IN THE ED. PIJR 2020. [DOI: 10.36106/paripex/9708058] [Reference Citation Analysis]
4 Kenan G, Kushnir M, Leonov Y, Ilgiyaev E, Aroesty R, Bhonkar S, Kimiagar I, Armon C. Electrophysiological features and prognosis of Guillain-Barré syndrome in Israel: A single-center's 20 years' experience. Journal of the Neurological Sciences 2020;417:117074. [DOI: 10.1016/j.jns.2020.117074] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Shang P, Zhu M, Wang Y, Zheng X, Wu X, Zhu J, Feng J, Zhang HL. Axonal variants of Guillain-Barré syndrome: an update. J Neurol 2021;268:2402-19. [PMID: 32140865 DOI: 10.1007/s00415-020-09742-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
6 Leung C. A lesson learnt from the emergence of Zika virus: What flaviviruses can trigger Guillain‐Barré syndrome? J Med Virol 2020;92:2938-45. [DOI: 10.1002/jmv.25717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Ding X, Jiang H, Hu X, Ren H, Cai H. Guillain-Barré Syndrome and Low Back Pain: Two Cases and Literature Review. Open Med (Wars) 2018;13:503-8. [PMID: 30426088 DOI: 10.1515/med-2018-0074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Koga M, Kishi M, Fukusako T, Kanda T. Distal limb weakness phenotype of Guillain-Barré syndrome. Journal of the Neurological Sciences 2018;392:83-8. [DOI: 10.1016/j.jns.2018.07.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nishiguchi S, Branch J, Tsuchiya T, Ito R, Kawada J. Guillain-Barré Syndrome: A Variant Consisting of Facial Diplegia and Paresthesia with Left Facial Hemiplegia Associated with Antibodies to Galactocerebroside and Phosphatidic Acid. Am J Case Rep 2017;18:1048-52. [PMID: 28966341 DOI: 10.12659/ajcr.904925] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
10 Nayak R. Practical approach to the patient with acute neuromuscular weakness. World J Clin Cases 2017; 5(7): 270-279 [PMID: 28798922 DOI: 10.12998/wjcc.v5.i7.270] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
11 Linenberger ML, Price TH. Use of Cellular and Plasma Apheresis in the Critically Ill Patient: Part II: Clinical Indications and Applications. J Intensive Care Med 2005;20:88-103. [DOI: 10.1177/0885066604273479] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
12 Kumar P, Charaniya R, Bahl A, Ghosh A, Dixit J. Facial Diplegia with Paresthesia: An Uncommon Variant of Guillain-Barre Syndrome. J Clin Diagn Res 2016;10:OD01-2. [PMID: 27630886 DOI: 10.7860/JCDR/2016/19951.8092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
13 Draak THP, Gorson KC, Vanhoutte EK, van Nes SI, van Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies ISJ; PeriNomS Study Group. Does ability to walk reflect general functionality in inflammatory neuropathies? J Peripher Nerv Syst 2016;21:74-81. [DOI: 10.1111/jns.12167] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
14 Mohite AA, Agius-Fernandez A. Chikungunya fever presenting with acute optic neuropathy. BMJ Case Rep 2015;2015:bcr2015210081. [PMID: 26220983 DOI: 10.1136/bcr-2015-210081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
15 Verma R, Chaudhari TS, Giri P. Unilateral facial palsy in Guillain-Barre syndrome (GBS): a rare occurrence. BMJ Case Rep 2012;2012:bcr2012007077. [PMID: 23087283 DOI: 10.1136/bcr-2012-007077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
16 Meena AK, Khadilkar SV, Murthy JM. Treatment guidelines for Guillain-Barré Syndrome. Ann Indian Acad Neurol 2011;14:S73-81. [PMID: 21847334 DOI: 10.4103/0972-2327.83087] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
17 Umapathi T, Yuki N. Pain in Guillain-Barré syndrome. Expert Rev Neurother 2011;11:335-9. [PMID: 21375438 DOI: 10.1586/ern.11.8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
18 Randall DP. Guillain-Barré syndrome. Dis Mon 2010;56:256-61. [PMID: 20493302 DOI: 10.1016/j.disamonth.2010.02.004] [Reference Citation Analysis]
19 Randall DP. Treatment of Guillain-Barré Syndrome. Disease-a-Month 2010;56:279-87. [DOI: 10.1016/j.disamonth.2010.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Sejvar JJ, Lindblade KA, Arvelo W, Padilla N, Pringle K, Zielinski-Gutierrez E, Farnon E, Schonberger LB, Dueger E. Clinical assessment of self-reported acute flaccid paralysis in a population-based setting in Guatemala. Am J Trop Med Hyg 2010;82:712-6. [PMID: 20348524 DOI: 10.4269/ajtmh.2010.09-0090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Hughes RAC. Treating nerves: a call to arms. Journal of the Peripheral Nervous System 2008;13:105-11. [DOI: 10.1111/j.1529-8027.2008.00166.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
22 Crone C, Krarup C. Diagnosis of acute neuropathies. J Neurol 2007;254:1151-69. [DOI: 10.1007/s00415-007-0532-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Sethi NK, Torgovnick J, Arsura E, Johnston A, Buescher E. Facial diplegia with hyperreflexia--a mild Guillain-Barre Syndrome variant, to treat or not to treat? J Brachial Plex Peripher Nerve Inj 2007;2:9. [PMID: 17425795 DOI: 10.1186/1749-7221-2-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
24 Green DM. Weakness in the ICU: Guillain-Barré syndrome, myasthenia gravis, and critical illness polyneuropathy/myopathy. Neurologist 2005;11:338-47. [PMID: 16286877 DOI: 10.1097/01.nrl.0000163784.17602.57] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
25 Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005;366:1653-66. [PMID: 16271648 DOI: 10.1016/S0140-6736(05)67665-9] [Cited by in Crossref: 991] [Cited by in F6Publishing: 819] [Article Influence: 55.1] [Reference Citation Analysis]
26 Peltier A, Russell J. Acute Inflammatory Demyelinating Polyradiculoneuropathy (Guillain–Barre´ Syndrome). Neurological Disease and Therapy 2005. [DOI: 10.1201/b14157-11] [Reference Citation Analysis]
27 Kogos SC, Richards JS, Baños J, Schmitt MM, Brunner RC, Meythaler JM, Salisbury DB, Renfroe SG, White AJ. A Descriptive Study of Pain and Quality of Life following Guillain-Barré Syndrome: One Year Later. J Clin Psychol Med Settings 2005;12:111-6. [DOI: 10.1007/s10880-005-3271-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
28 van Doorn PA. Treatment of Guillain-Barre syndrome and CIDP. J Peripher Nerv Syst 2005;10:113-27. [DOI: 10.1111/j.1085-9489.2005.0010203.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
29 Urban PP, Nix WA. Guillain-Barré-Syndrom. Notfall & Rettungsmedizin 2005;8:281-285. [DOI: 10.1007/s10049-005-0739-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
30 Ashton C, Hendrickson CD. Guillain-Barré syndrome in a collegiate football player. Clin J Sport Med 2004;14:48-9. [PMID: 14712167 DOI: 10.1097/00042752-200401000-00009] [Reference Citation Analysis]
31 Krarup C. Compound sensory action potential in normal and pathological human nerves. Muscle Nerve 2004;29:465-83. [DOI: 10.1002/mus.10524] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
32 Storm S, Weiss MD. Self-inflicted tourniquet paralysis mimicking acute demyelinating polyneuropathy. Muscle Nerve 2003;27:631-5. [PMID: 12707986 DOI: 10.1002/mus.10366] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
33 Green DM. Advances in the management of Guillain-Barré syndrome. Curr Neurol Neurosci Rep 2002;2:541-8. [DOI: 10.1007/s11910-002-0043-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
34 van Doorn PA, Garssen MP. Treatment of immune neuropathies: . Current Opinion in Neurology 2002;15:623-31. [DOI: 10.1097/00019052-200210000-00014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
35 Krarup C. Nerve conduction studies in selected peripheral nerve disorders: . Current Opinion in Neurology 2002;15:579-93. [DOI: 10.1097/00019052-200210000-00009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]